当前位置:首页 - 行情中心 - 美农生物(301156) - 财务分析 - 现金流量表

美农生物

(301156)

  

流通市值:13.26亿  总市值:25.02亿
流通股本:7462.48万   总股本:1.41亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金268,239,808.32142,209,428.24491,869,108.06343,529,888.82
  客户存款和同业存放款项净增加额-0-0
  向中央银行借款净增加额-0-0
  向其他金融机构拆入资金净增加额-0-0
  收到原保险合同保费取得的现金-0-0
  收到再保险业务现金净额-0-0
  保户储金及投资款净增加额-0-0
  收取利息、手续费及佣金的现金-0-0
  拆入资金净增加额-0-0
  回购业务资金净增加额-0-0
  收到的税费返还4,655,723.771,525,794.357,582,202.574,893,748.11
  收到其他与经营活动有关的现金2,633,552.95770,863.268,039,777.095,357,550.24
  经营活动现金流入的其他项目-0-0
  经营活动现金流入小计275,529,085.04144,506,085.85507,491,087.72353,781,187.17
  购买商品、接受劳务支付的现金166,364,232.2876,416,436.18308,998,145.82215,340,802.2
  客户贷款及垫款净增加额-0-0
  存放中央银行和同业款项净增加额-0-0
  支付原保险合同赔付款项的现金-0-0
  支付利息、手续费及佣金的现金-0-0
  支付保单红利的现金-0-0
  支付给职工以及为职工支付的现金42,683,779.7424,742,480.1779,614,29962,606,136.85
  支付的各项税费7,106,588.44,059,838.9610,156,979.377,530,926.54
  支付其他与经营活动有关的现金19,109,204.88,655,290.2441,556,227.5223,472,381.83
  经营活动现金流出的其他项目-0-0
  经营活动现金流出小计235,263,805.22113,874,045.55440,325,651.71308,950,247.42
  经营活动产生的现金流量净额40,265,279.8230,632,040.367,165,436.0144,830,939.75
二、投资活动产生的现金流量:
  收回投资收到的现金105,000,00020,000,000369,070,000308,000,000
  取得投资收益收到的现金914,762.01266,925.91,217,183.82993,025.75
  处置固定资产、无形资产和其他长期资产收回的现金净额8,0008,000413,670.43416,830
  处置子公司及其他营业单位收到的现金净额-0-0
  收到的其他与投资活动有关的现金538,7008,7001,400,0000
  投资活动现金流入小计106,461,462.0120,283,625.9372,100,854.25309,409,855.75
  购建固定资产、无形资产和其他长期资产支付的现金71,894,303.2517,078,202.9855,942,134.715,586,742.18
  投资支付的现金65,000,0000379,070,000359,070,000
  质押贷款净增加额-0-0
  取得子公司及其他营业单位支付的现金-0-0
  支付其他与投资活动有关的现金3,810,0003,480,0001,400,0000
  投资活动现金流出小计140,704,303.2520,558,202.98436,412,134.7374,656,742.18
  投资活动产生的现金流量净额-34,242,841.24-274,577.08-64,311,280.45-65,246,886.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0-0
  其中:子公司吸收少数股东投资收到的现金-0-0
  取得借款收到的现金-01,000,0001,000,000
  收到其他与筹资活动有关的现金-0-0
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-01,000,0001,000,000
  偿还债务支付的现金-01,000,0001,000,000
  分配股利、利润或偿付利息支付的现金43,184,279.83060,858,385.3960,858,385.36
  其中:子公司支付给少数股东的股利、利润-0-0
  支付其他与筹资活动有关的现金18,032,711.3918,011,119.2543,927,438.0430,350,372.27
  筹资活动现金流出小计61,216,991.2218,011,119.25105,785,823.4392,208,757.63
  筹资活动产生的现金流量净额-61,216,991.22-18,011,119.25-104,785,823.43-91,208,757.63
四、汇率变动对现金及现金等价物的影响848,034.59805,052.242,326,466.84419,434.23
五、现金及现金等价物净增加额-54,346,518.0513,151,396.21-99,605,201.03-111,205,270.08
  加:期初现金及现金等价物余额260,247,859.66260,247,859.66359,853,060.69359,853,060.69
  期末现金及现金等价物余额205,901,341.61273,399,255.87260,247,859.66248,647,790.61
补充资料:
  净利润23,527,034.24-49,582,532.45-
  资产减值准备509,585.71-1,361,351.3-
  固定资产和投资性房地产折旧11,660,716.92-21,822,676.53-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,660,716.92-21,822,676.53-
  无形资产摊销1,156,615.23-1,587,904.78-
  长期待摊费用摊销1,322,865.16-1,414,675.18-
  处置固定资产、无形资产和其他长期资产的损失7,466.29--353,738.08-
  固定资产报废损失--37,754.5-
  公允价值变动损失107,596.46--1,317,711.16-
  财务费用-843,068.87--2,286,227.07-
  投资损失-1,345,543.15-245,512.43-
  递延所得税296,815.87-192,935.15-
  其中:递延所得税资产减少296,815.87-192,935.15-
    递延所得税负债增加0---
  存货的减少-4,355,317.83-8,870,748.46-
  经营性应收项目的减少9,961,867.39--25,744,390.62-
  经营性应付项目的增加-2,179,521.56-9,485,382.39-
  其他--0-
  现金的期末余额205,901,341.61-260,247,859.66-
  减:现金的期初余额260,247,859.66-359,853,060.69-
  现金及现金等价物的净增加额-54,346,518.05--99,605,201.03-
公告日期2025-08-282025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑